Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 1;110(3):799-803.
doi: 10.3324/haematol.2024.286343.

Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis

Affiliations

Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis

Bryan Valcarcel et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hazard ratios for overall survival across antiretroviral therapy periods (2001-2016) in a matched cohort (A) and subgroup analyses within demographic groups (B-D). Estimates for Other race and ethnicity are not shown. P values reflect the likelihood ratio test comparing model fit with and without the interaction term of HIV and calendar year. CI: Confidence Interval; HR: Hazard Ratio; NHB: Non-Hispanic Black; NHW: Non-Hispanic White. Derived from 13 Surveillance, Epidemiology, and End Results registries.
Figure 2.
Figure 2.
Kaplan-Meier curves evaluating the effect of human immunodeficiency virus status on overall survival among all included patients (A) and selected demographic groups (B-D). Remarkable survival differences are shown, with diffuse large B-cell lymphoma in the contemporary matched cohort (2008-2016). HIV: human immunodeficiency virus. Derived from 13 Surveillance, Epidemiology, and End Results registries.

References

    1. Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495-e504. - PMC - PubMed
    1. Conconi A, Zucca E, Margiotta-Casaluci G, et al. . Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematol Oncol. 2018;36(5):757-764. - PubMed
    1. Coutinho R, Pria AD, Gandhi S, et al. . HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era. AIDS. 2014;28(5):689-697. - PubMed
    1. Besson C, Lancar R, Prevot S, et al. . Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era. AIDS. 2017;31(18):2493-2501. - PubMed
    1. Olszewski AJ, Fallah J, Castillo JJ. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Cancer. 2016;122(17):2689-2697. - PubMed

LinkOut - more resources